Physician profile
Patrick Krzyzewski
NPI 1053496067
$2,508.70
in general payments reported to CMS, 2019-2025
20 companies · $593 in 2025
The $593 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $331 · 2021: $588 · 2022: $293 · 2023: $101 · 2024: $602 · 2025: $593.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,296.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,296.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $414.82 | 2019-2025 | Stravix, Grafix Pl, Oasis |
| Kerecis Limited | $344.56 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Horizon Therapeutics Plc | $201.01 | 2021 | |
| Orthofix Medical, INC. | $174.93 | 2024 | Physio-Stim |
| Bard Peripheral Vascular, INC. | $170.06 | 2025 | Venovo |
| Mimedx Group, INC. | $149.69 | 2024 | |
| Nevro Corp. | $145.25 | 2022 | |
| Neurocrine Biosciences, INC. | $138.87 | 2021 | |
| Sanara Medtech INC. | $133.99 | 2021 | |
| Medtronic, INC. | $121.70 | 2025 | Intellis Adaptivestim |
| Organogenesis INC. | $114.37 | 2021 | |
| Depuy Synthes Sales INC. | $99.99 | 2019 | |
| Stryker Corporation | $78.52 | 2024 | Ortholoc 3di |
| Solventum Corporation | $67.59 | 2024 | V.A.C. Veraflo Cleanse Choice, Prevena |
| Treace Medical Concepts, INC. | $37.28 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orexo US, INC. | $37.12 | 2019 | |
| Indivior INC. | $31.05 | 2019 | |
| Zimmer Biomet Holdings, INC. | $22.43 | 2022 | |
| Enduromed, LLC | $13.80 | 2023 | |
| Eisai INC. | $11.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Krzyzewski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.